Professional Documents
Culture Documents
DENGUE FEVER
y Endemic throughout the tropics and subtropics y Caribbean, including Puerto Rico and the US
DENGUE FEVER
Causative Agent: Dengue viruses Mode of Entry: y Transmitted to human through the bites of infective female Aedes mosquitos.
y Low flying, day biting, parallel landing, tiger
DENGUE FEVER
SYSTEM AFFECTED: Circulatory system INCUBATION PERIOD: Uncertain. Approximately 6 days to 1 week PERIOD OF COMMUNICABILITY: Unknown. Presumed to be on the 1st week of illness (virus is still present in the blood).
DENGUE FEVER
SYMPTOMS: 1ST 4 days-febrile or invasive stage1. abrupt high fever 2. Abdominal pain 3. Muscle pain 4. Joint pain 5. Headache Late: 1. Flushing 2. vomiting 3. conjunctival infection 4. epistaxis
DENGUE FEVER
ETIOLOGY:
y Different strains of dengue virus y Transmitted by mosquitoes (genus Aedes) y Aedes Aegypti
DENGUE FEVER
PATHOPHYSIOLOGY:
y Symptoms begin after a 5-10 days incubation period y Illness begins abruptly with a minor stage of 2-4 days
DIC may be mediated by circulating dengue antigenantibody complexes, activation of complement, and release of vasoactive amines.
DENGUE FEVER
In the process of immune elimination of infected cells, proteases and lymphokines may be released and activate complement coagulation cascades and vascular permeability.
DENGUE FEVER
CLINICAL FINDINGS: SUBJECTIVE 1. Headache 2. Nausea 3. Vomiting 4. Loss of appetite 5. Abdominal pain 6. Bone and joint pain
DENGUE FEVER
OBJECTIVE: 1. Anorexia 2. Petechiae 3. Melena 4. Hematochezia 5. Hypotension 6. Fever 7. Rapid pulse 8. Rashes over thorax 9. leukopenia
DENGUE FEVER
DIAGNOSTIC TEST: Tourniquet Test (Rumpel Leads Test)
1. 2. 3. 4. 5.
(Systolic pressure + Diastolic pressure)/2 Keep the pressure for 5 minutes Release 2.5 cm (1 sq. inch) Count the number of petechiae inside the box
DENGUE FEVER
Acute convalescent serum (measures an increase in antibody titer for dengue virus type). Serologic studies (demonstrates antibodies to dengue viruses, type-specific) Dengue Dot Platelet count
DENGUE FEVER
MEDICAL TREATMENT: 1. Rehydration (IVF, oresol) 2. Acetaminophen or Paracetamol (do not give ASA) 3. Supportive 4. Symptomatic NURSING INTERVENTION: Preventive Measures 1. No vaccine available
DENGUE FEVER
Preventive Measures:
2. 3. 4. 5. 6. 7.
Personal protection (repellant, net) Early recognition Isolation of patient Epidemiological investigation Case finding and reporting Health education
DENGUE FEVER
CONTROL MEASURES
1. 2.
DENGUE FEVER
COMPLICATIONS
6. 7. 8. 9. 10.
Encephalitis
Description:
y Encephalitis is an inflammation of cerebral tissue, typically
encephalomyelitis.
Encephalitis
Pathophysiology and Etiology
y Acute viral encephalitis, accounting for the vast majority of cases, is
destruction.
y More common in children, and is most commonly
caused by the herpes simplex virus and, to a lesser degree, by the arboviruses.
Encephalitis
y Pathophysiology and Etiology
Encephalitis
y Postinfectious encephalomyelitis follows a viral or bacterial
infectious process, but organisms do not directly affect the neural tissue in the white matter; however, perivascular inflammation and demyelination do occur in the cerebral tissue.
y The incidence of postinfectious encephalomyelitis has
decreased considerably with immunization against measles, mumps, and rubella and the infrequent administration of vaccines due to the eradication of smallpox.
y Rare in infancy.
Encephalitis
y The most common cause is respiratory or GI infection
ticks (arthropods), which may be seasonal and geographic hosts (eg, California encephalitis, St. Louis equine encephalitis).
Encephalitis
y Herpes simplex encephalitis may result from reactivation of the
virus that has been dormant in the cranial and other ganglia, or to reinfection.
y Direct spread to the brain by the olfactory or trigeminal
encephalitis
y Cytomegalovirus encephalitis should be considered
in patients who have advanced HIV infection, have evidence of the cytomegalovirus in other sites, and have progressive neurologic deterioration.
Encephalitis
Clinical Manifestations y ICP may result in alteration in consciousness, nausea, and vomiting. y Seizures may be present. y Motor weakness, such as hemiparesis, may be detected. y Increased deep tendon reflexes and extensor plantar response are noted. y Fever may be present. y Headache may indicate signs of meningeal irritation.
Encephalitis
Clinical Manifestations y Bizarre behavior and personality changes may present at onset.
y Hypothalamic-pituitary involvement may result in
field defects, aphasia, dysphagia, ataxia, syndrome of inappropriate antidiuretic hormone (SIADH), and paresthesias.
Encephalitis
Complications
Sequelae of the herpes simplex virus may cause temporal lobe swelling, which can result in compression of the brain stem. This virus may also cause aphasia, major motor and sensory deficits, and Korsakoffs psychosis (amnestic syndrome).
encephalitis
y
Relapse of encephalitis may be seen after initial improvement and completion of antiviral therapy. Mortality and morbidity rates depend on the infectious agent, host status, and other considerations. With herpes simplex, the mortality rate is approximately 30%.
Encephalitis
Diagnostic Test
y
Lumbar puncture with evaluation of CSF is performed to detect leukocytosis, increased mononuclear cell pleocytosis, increased proteins, and normal or slightly lowered glucose.
ENCEPHALITIS
y
Polymerase chain reaction (PCR) analysis of the virus DNA and the detection of intrathecally produced viral antibodies are essential in diagnosing the specific virus (eg, herpes simplex virus, cytomegalovirus). Arbovirus-specific IgM in CSF and a fourfold change in specific IgG antibody are diagnostic for arboviral encephalitis. EEG may demonstrate slow brain wave complexes in encephalitis.
Encephalitis
Diagnostic Test y Gadolinium-enhanced MRI differentiates postinfectious
Encephalitis
Diagnostic Test
y Herpes simplex virus encephalitis typically has medial-
temporal and orbital-frontal lobe inflammation and necrosis; there may be low-density abnormalities in the temporal lobes.
y Cytomegalovirus, seen in patients who have advanced HIV
organisms.
Encephalitis
Treatment/ Medical Management
y
Differentiate acute viral encephalitis from noninfectious diseases such as sarcoidosis, vasculitism, systemic lupus erythematosis, and others.
In patients who are immunosuppressed, such as HIV+ patients, differentiate acute viral encephalitis from cytomegalovirus encephalitis, toxoplasmic encephalitis, and fungal infections.
Encephalitis
Treatment/ Medical Management
y
Patients with cytomegalovirus may be treated with ganciclovir (Cytovene) and foscarnet (Foscavir), commonly used to treat cytomegalovirus retinitis in HIV+ patients. Pyrimethamine (Daraprim) and sulfadoxine (Fansidar) are commonly used to treat Toxoplasma encephalitis. When encephalomyelitis develops, supportive care is indicated because there is no known treatment; corticosteroids may be used.
Encephalitis
Treatment/ Medical Management
y
Patients with cytomegalovirus may be treated with ganciclovir (Cytovene) and foscarnet (Foscavir), commonly used to treat cytomegalovirus retinitis in HIV+ patients. Pyrimethamine (Daraprim) and sulfadoxine (Fansidar) are commonly used to treat Toxoplasma encephalitis. When encephalomyelitis develops, supportive care is indicated because there is no known treatment; corticosteroids may be used.
y y
Encephalitis
y IV acyclovir over 10 days to 3 weeks duration is indicated for
who have genital herpes simplex may be treated with acyclovir during the third trimester to avoid shedding the virus to their babies.
y Anticonvulsants manage seizures.
Encephalitis
Nursing Management
y Nursing Assessment y Obtain patient history of recent infection, animal
history of congenital herpes simplex virus and examined for evidence of this virus; a cesarean section should be explored with the physician.
Encephalitis
Nursing Management
y Nursing Assessment y Strict universal (standard) precautions should be adhered
Encephalitis
Nursing Management y Preventing Injury
y Maintain quiet environment and provide care gently,
adverse reactions.
Encephalitis
Nursing Management y Promoting Cerebral Perfusion
y Monitor neurologic status closely. y Observe for subtle changes, such as behavior or
personality changes, weakness, or cranial nerve involvement. Notify health care provider.
y In arbovirus encephalitis, restrict fluids to passively
Encephalitis
Nursing Management y Promoting Cerebral Perfusion
y Reorient patient frequently. y Provide supportive care if coma develops; may last several
weeks.
y Encourage significant others to interact with patient, and
Encephalitis
Nursing Management y Relieving Fever
y Monitor temperature and vital signs frequently. y Administer antipyretics and other cooling measures as indicated. y Monitor fluid intake and output, and provide fluid replacement through
IV lines as needed.
y Be alert to signs of other coexisting infections, such as urinary tract
infection or pneumonia, and notify health care provider so cultures can be obtained and treatment started.
Encephalitis
Nursing Management y Managing Aberrations in Thought Processes
y Orient to person, place, time. y Maintain memory book, and provide cues to perform required
activities.
y Avoiding Infectious Disease Transmission y Maintain strict universal (standard) precautions. y Initiate and maintain isolation per facility policy.
Encephalitis
Community and Home Care Considerations y Promote vaccination of patient/family/significant others for measles, mumps, and rubella.
y Pregnant women who have a history of genital herpes
prophylaxis.
Encephalitis
Patient Education and Health Maintenance y Explain the effects of the disease process and the rationale for care.
y Reassure significant others based on patients prognosis. y Encourage follow-up for evaluation of deficits and
rehabilitation progress.
y Educate others about the signs and symptoms of encephalitis
in case of an epidemic.